AMCPX: Congress and insider trades

Who in Congress and inside the company traded AMCPX, when each filing appeared, and what buying after each one would have earned against the S&P 500.

Key Facts

  • AMCPX is a listed stock.
  • 2 members of Congress filed 1 buy and 1 sell of AMCPX, the latest published 2026-09-14 (14 September 2026).
  • Across 1 scored buy, Congress averaged -1.8% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell.
  • Data as of 2026-09-29 (29 September 2026).
Congress buys 1 2 members
Congress sells 1
Insider buys 0 $0
Insider sells 0 $0
Congress buys vs S&P, 90d -1.8% 1 scored buys
Insider buys vs S&P, 90d n/a 0 scored buys

Congress trades in AMCPX

as of 2026-09-14
  1. John Rose1 trade
  2. Mike Conaway1 trade
Congress trades in AMCPX, newest first.
FiledMemberTypeSizeDays to file90 day vs S&P
14 Sep 2026 John Rose (R-TN) sell 500K–1M 466 n/a
23 Jan 2021 Mike Conaway (R-TX) buy 50K–100K 36 -1.8%

Frequently asked questions

Who has bought AMCPX?

1 Congress buy by 2 members and 0 insider buys are on file. The tables on this page list every one.

Did buying AMCPX after a disclosure beat the market?

Across 1 scored buy, Congress averaged -1.8% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell. A single stock is a small sample.

Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.